NLRP3 and Alzheimer disease: Consequently, elucidating the mechanisms of NLRP3 inflammasome assembly and activation, as well as developing molecular therapeutic strategies targeting downstream components of the inflammasome, could enhance our understanding of AD pathogenesis.